This was the stock's second consecutive day of losses.

In a report released yesterday, David Toung from Argus Research maintained a Buy rating on Elevance Health (ELV – Research Report). The ...

Argus raised the firm’s price target on Elevance Health (ELV) to $465 from $450 and keeps a Buy rating on the shares. The company’s results ...

UnitedHealth Group Incorporated UNH has plunged 26.9% since reporting disappointing first-quarter 2025 results and slashing ...

The Dow Jones Industrial Average surged 2,159 points, or 5.7%, while the S&P 500 rallied 6%. The Nasdaq Composite posted the strongest gain, up 8%, snapping a four-day rout fueled by tariff fears.

The stock's rise snapped a four-day losing streak.

The Dow Jones Industrial Average fell 527 points on Friday, creating dramatic headlines about market turmoil. Yet ...

A surprising Medicare Advantage cost spike helped push UnitedHealth into a rare deep dive Thursday, after the health care ...

UnitedHealth Group stock had one of its worst days ever on Thursday after the healthcare giant unexpectedly cut its profit ...

A surprising Medicare Advantage cost spike helped push UnitedHealth into a rare deep dive Thursday, after the health care ...

For 2025, UnitedHealth now predicts adjusted earnings ranging from $26 to $26.50 per share. The Eden Prairie, Minnesota, ...

MINNETONKA, Minn. — A surprising cost spike from Medicare Advantage plans helped push UnitedHealth shares into a dive ...